ANO4 | Anoctamin 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
ANO6 | Anoctamin 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AOC3 | Amine oxidase, copper containing 3 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AP5S1 | Adaptor-related protein complex 5, sigma 1 subunit | Predicted membrane proteins
| | | | | Expressed in all |
APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APH1A | APH1A gamma secretase subunit | Predicted membrane proteins
| | | | | Expressed in all |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APMAP | Adipocyte plasma membrane associated protein | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4 | Apolipoprotein C-IV | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APOL6 | Apolipoprotein L, 6 | Predicted membrane proteins
| | | | | Expressed in all |
APOM | Apolipoprotein M | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP1 | Aquaporin 1 (Colton blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Not detected |
AQP12A | Aquaporin 12A | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP12B | Aquaporin 12B | Predicted membrane proteins
| | | | | Tissue enriched |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP6 | Aquaporin 6, kidney specific | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQPEP | Aminopeptidase Q | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AQR | Aquarius intron-binding spliceosomal factor | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ARFGEF1 | ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited) | | | | | | Expressed in all |
ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | Disease related genes
| | | | | Expressed in all |
ARHGAP1 | Rho GTPase activating protein 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 | Plasma proteins
| | | | | Expressed in all |
ARHGEF10L | Rho guanine nucleotide exchange factor (GEF) 10-like | | | | | | Expressed in all |
ARHGEF28 | Rho guanine nucleotide exchange factor (GEF) 28 | | | | | | Mixed |
ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 | Predicted membrane proteins
| | | | | Expressed in all |
ARRB1 | Arrestin, beta 1 | | | | | | Expressed in all |
ARSB | Arylsulfatase B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ARSD | Arylsulfatase D | Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Tissue enhanced |
ARSG | Arylsulfatase G | Predicted secreted proteins
| | | | | Mixed |
ART3 | ADP-ribosyltransferase 3 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ASGR1 | Asialoglycoprotein receptor 1 | | | | | | Tissue enriched |